Are there any new allergy eye drops this year that effectively target both mast cell stabilization and dual action histamine receptor antagonism for chronic red itchy eyes
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Are there any new allergy eye drops this year that effectively target both mast cell stabilization and dual action histamine receptor antagonism for chronic red itchy eyes
2 real searches · 1 real-search pass
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 2 queries…
Searches and sources
ChatGPT2 real searches · gpt-6
2026 new FDA approved allergic conjunctivitis eye drops mast cell stabilizer antihistamine dual action Google ↗
2026 ophthalmic allergy eye drops launch approval olopatadine ketotifen bepotastine alcaftadine Google ↗
- Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S. · nasdaq.com
- NDC 51316-633-02 Allergy Relief Eye Drops… · fda.report
- American Academy of Allergy Asthma & Immunology · aaaai.org
- DailyMed · dailymed.nlm.nih.gov
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 new FDA approved allergic conjunctivitis eye drops mast cell stabilizer antihistamine dual action OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
2026 ophthalmic allergy eye drops launch approval olopatadine ketotifen bepotastine alcaftadine OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |